Sun pharma adv share price history

Sun Pharma Advanced Research Company Ltd. share price down by down by-2.05%-2.15% from its previous close of Rs 104.85 104.70. Sun Pharma Advanced Research Company Ltd. stock last traded price is 102.70 102.45 ICICI Securities upgrades Sun Pharma to buy, raises target price to Rs 478 - 5 day(s) ago Analyst Calls: Tata Motors, Sun Pharma, BPCL, MFSL, NTPC - 6 day(s) ago BSE Announcements from Sun Pharmaceutical Industries Ltd.

- In June 2000, Sun Pharma merged its 99.28% subsidiary - Sun Pharmaceuticals Exports. 2001 - Sun Pharmaceutical Industries Ltd has approved the merger of the ailing Pradeep Drug Company Ltd. - Sun Pharmaceutical Industries Ltd. is to merge its research arm Sun Pharmaceutical Advanced Research Centre Ltd. The product will be manufactured by Sun Pharmaceutical Industries Ltd at its Halol (Gujarat) facility in India.On 9 June 2015 Sun Pharma Advanced Research Company Ltd. (SPARC) and Sun Pharmaceutical Industries Ltd. announced that SPARC has licensed out Xelpros (Latanoprost BAK-free eye drops) to a subsidiary of Sun Pharma for the US market. Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Sun Pharmaceutical Inds. Ltd.. From Indias independent mutual fund research house Moneycontrol Technical Chart Analysis of Sun Pharma, BSE/NSE Market chart analysis,live market index & techical information with graph in advance features. History of Sun Pharmaceutical Industries Ltd. Company including its incorporation date. Check goodreturns.in for a complete historical background of Sun Pharmaceutical Industries Ltd.. Sun Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times. The founding family continues to hold a majority stake in the company. Today Sun Pharma is the second largest and the most profitable pharmaceutical company in India, as well as the largest pharmaceutical company by market capitalisation on the Indian Sun Pharma demerges Sun Pharma Advanced Research Company (SPARC), into a separate entity becoming the first pure research company to be listed on Indian stock exchanges 2013 Ranbaxy acquisition catapults Sun Pharma to world’s 5th largest specialty generic pharmaceutical company

Sun Pharma Advanced Research Company Limited Stock Trends in 2018. On January 2, 2018, the share price of Sun Pharma Advanced Research Company was reported to be at Rs.503.90 on the NSE. The price rose by a little over 5% in the first half of the month to reach its 52-week high at Rs.532.

Get Sun Pharma Advanced Research Company Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details. The Prices page of Sun Pharma Advanced Research Company Ltd.. captures the information on Price and Volume for a user defined time interval. It also contains the Live Stock Price and Volume, 52 Week High Low, Bid and Offer Price and Volume, Intraday and Historical Price Chart. Sun Pharma Advanced Research Company Ltd. share price down by down by-2.05%-2.15% from its previous close of Rs 104.85 104.70. Sun Pharma Advanced Research Company Ltd. stock last traded price is 102.70 102.45 ICICI Securities upgrades Sun Pharma to buy, raises target price to Rs 478 - 5 day(s) ago Analyst Calls: Tata Motors, Sun Pharma, BPCL, MFSL, NTPC - 6 day(s) ago BSE Announcements from Sun Pharmaceutical Industries Ltd.

Share Price, Corporate Actions, Valuation, Research Report, Financials and more - complete track record of Sun Pharmaceutical Inds. Ltd.. From Indias independent mutual fund research house

ICICI Securities upgrades Sun Pharma to buy, raises target price to Rs 478 - 5 day(s) ago Analyst Calls: Tata Motors, Sun Pharma, BPCL, MFSL, NTPC - 6 day(s) ago BSE Announcements from Sun Pharmaceutical Industries Ltd. Sun Pharma third-quarter profit jumps four-fold on strong U.S. show Net profit came in at 12.42 billion rupees ($175.45 million) versus 3.22 billion rupees profit last year, the company said, which was above an average estimate for a profit of 9.86 billion rupees from 16 analysts, Refinitiv Eikon data shows. The upper and lower price bands, for scrips on which derivative products are available or scrips included in indices on which derivative products are available, are on the basis of dynamic price band of 10%. In the event of a market trend in either direction, the dynamic price bands may be relaxed during the day in co-ordination with other For the year ending March 2019 Sun Pharmaceutical Industries has declared an equity dividend of 275.00% amounting to Rs 2.75 per share. At the current share price of Rs 370.15 this results in a Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics. Company History - Sun Pharma Advanced Research Company Ltd. 2007 - Sun Pharma Advanced Research Co.Ltd was formed in the year 2007, with separation of India's leading specialty pharma company, Sun Pharmaceutical Industries Ltd, and its active projects in drug discovery and innovation into a new company. Sun Pharma Advanced Research Company Limited Stock Trends in 2018. On January 2, 2018, the share price of Sun Pharma Advanced Research Company was reported to be at Rs.503.90 on the NSE. The price rose by a little over 5% in the first half of the month to reach its 52-week high at Rs.532.

Sun Pharma Advanced Research Company Ltd. share price down by down by-2.05%-2.15% from its previous close of Rs 104.85 104.70. Sun Pharma Advanced Research Company Ltd. stock last traded price is 102.70 102.45

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. If you wish to learn more about the program, please click Continue.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. If you wish to learn more about the program, please click Continue.

The upper and lower price bands, for scrips on which derivative products are available or scrips included in indices on which derivative products are available, are on the basis of dynamic price band of 10%. In the event of a market trend in either direction, the dynamic price bands may be relaxed during the day in co-ordination with other

The upper and lower price bands, for scrips on which derivative products are available or scrips included in indices on which derivative products are available, are on the basis of dynamic price band of 10%. In the event of a market trend in either direction, the dynamic price bands may be relaxed during the day in co-ordination with other For the year ending March 2019 Sun Pharmaceutical Industries has declared an equity dividend of 275.00% amounting to Rs 2.75 per share. At the current share price of Rs 370.15 this results in a Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in speciality generics. Company History - Sun Pharma Advanced Research Company Ltd. 2007 - Sun Pharma Advanced Research Co.Ltd was formed in the year 2007, with separation of India's leading specialty pharma company, Sun Pharmaceutical Industries Ltd, and its active projects in drug discovery and innovation into a new company. Sun Pharma Advanced Research Company Limited Stock Trends in 2018. On January 2, 2018, the share price of Sun Pharma Advanced Research Company was reported to be at Rs.503.90 on the NSE. The price rose by a little over 5% in the first half of the month to reach its 52-week high at Rs.532. - In June 2000, Sun Pharma merged its 99.28% subsidiary - Sun Pharmaceuticals Exports. 2001 - Sun Pharmaceutical Industries Ltd has approved the merger of the ailing Pradeep Drug Company Ltd. - Sun Pharmaceutical Industries Ltd. is to merge its research arm Sun Pharmaceutical Advanced Research Centre Ltd.